Ivor Percent
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
-
- Cancer Genomics and Diagnostics
Papers in
- Oncology 29
- Cancer Immunotherapy and Biomarkers 12
- Colorectal Cancer Treatments and Studies 4
- Cancer Treatment and Pharmacology 4
-
- Renal cell carcinoma treatment 7
- Prostate Cancer Treatment and Research 6
- Lung Cancer Treatments and Mutations 5
- Co-authors
- Arash Rezazadeh Kalebasty (7 shared papers)Andres Forero‐Torres (5 shared papers)James Posey (2 shared papers)Tina E. Wood (2 shared papers)Slawomir Wojtowicz‐Praga (2 shared papers)Mansoor N. Saleh (5 shared papers)Jatin J. Shah (3 shared papers)Catherine Copigneaux (1 shared paper)
- Journals
- Journal of Clinical Oncology (16 papers)Annals of Oncology (7 papers)Cancer Biotherapy and Radiopharmaceuticals (2 papers)Cancer Research (2 papers)Cancer (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Ivor Percent
33 papers receiving 699 citations
Hit Papers
Peers
Comparison fields: 5 of 50
- Oncology 412
- Cancer Research 155
- Pulmonary and Respiratory Medicine 299
- Molecular Biology 371
- Immunology 78
Countries citing papers authored by Ivor Percent
This map shows the geographic impact of Ivor Percent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivor Percent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivor Percent more than expected).
Fields of papers citing papers by Ivor Percent
This network shows the impact of papers produced by Ivor Percent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivor Percent. The network helps show where Ivor Percent may publish in the future.
Co-authors
The 25 scholars most cited alongside Ivor Percent, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase 1/2 study of ARV-110, an androgen receptor (AR) PROTAC degrader, in metastatic castration-resistant prostate cancer (mCRPC). Hit paper breakdown → | 2022 | 125 |
| 2 | 2010 | 116 | |
| 3 | 2022 | 85 | |
| 4 | 2019 | 66 | |
| 5 | 2018 | 40 | |
| 6 | 2022 | 31 | |
| 7 | 2021 | 31 | |
| 8 | 2010 | 29 | |
| 9 | 2019 | 27 | |
| 10 | 2008 | 25 | |
| 11 | 2019 | 22 | |
| 12 | 2005 | 20 | |
| 13 | 2021 | 13 | |
| 14 | 2020 | 12 | |
| 15 | 2020 | 11 | |
| 16 | 2019 | 9 | |
| 17 | 2008 | 8 | |
| 18 | 2024 | 6 | |
| 19 | 2021 | 5 | |
| 20 | 2023 | 4 |
About Ivor Percent
Ivor Percent is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Epidemiology, having authored 33 papers that have together received 715 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (12 papers), Cancer Genomics and Diagnostics (8 papers), Renal cell carcinoma treatment (7 papers), Prostate Cancer Treatment and Research (6 papers), Lung Cancer Treatments and Mutations (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Breast Cancer Treatment Studies (4 papers) and Cancer Treatment and Pharmacology (4 papers). The work is most often cited by research in Oncology (412 citations), Cancer Research (155 citations), Pulmonary and Respiratory Medicine (299 citations), Molecular Biology (371 citations) and Immunology (78 citations). Ivor Percent has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Arash Rezazadeh Kalebasty, Andres Forero‐Torres, James Posey, Tina E. Wood, Slawomir Wojtowicz‐Praga, Mansoor N. Saleh, Jatin J. Shah, Catherine Copigneaux, Feng Luo and Thomas E. Hutson. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Biotherapy and Radiopharmaceuticals, Cancer Research and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.